Condition
Menstrual Regulation
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.9% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (1)
P 4 (3)
Trial Status
Completed2
Unknown1
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07671989Phase 4RecruitingPrimary
Period Pills for Menstrual Regulation: A New Reproductive Health Option
NCT04940013Phase 4TerminatedPrimary
Missed Period Pill Study
NCT03972358Phase 2UnknownPrimary
Assessing Medical Menstrual Regulation in the United States
NCT01798017Phase 4CompletedPrimary
Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh
NCT01954069Not ApplicableCompletedPrimary
Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service
Showing all 5 trials